Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Lung antibodies can be measured in exhaled breath (opens in a new tab)

medicalxpress.com · 2026-11-04

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Three of six claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

  • 3 supported
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredFor the first time, researchers have successfully measured antibodies against specific respiratory viruses in exhaled air.View evidenceHide evidence

As statedfor the first time

Why this verdict

The abstract-level profile supports that the study used non-invasive PExA sampling to quantify antigen-specific IgA and IgG in exhaled/distal-airway particles. However, the headline’s novelty claim, “for the first time,” is not verifiable from the supplied abstract-level profile. The headline therefore outruns what can be confirmed here.

1

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
Claim 2 of 6Not coveredThe new study, involving the Karolinska Institutet, was published in eBioMedicine, and the method may make it easier to study the immune system in the small airways of the lungs.View evidenceHide evidence

Why this verdict

The scientific portion is supported: the profile describes PExA as a non-invasive way to assess antigen-specific antibodies in distal-airway RTLF, relevant to studying lower-airway immunity. But the supplied paper profile does not verify the Karolinska affiliation or eBioMedicine publication detail, so the full presented claim is not fully verifiable at this evidence depth.

1

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
Claim 3 of 6Not coveredThe study included 28 participants in the COMMUNITY cohort at Danderyd Hospital, 18 of whom had recently experienced a respiratory tract infection, and paired samples were analyzed from blood, nasal secretions, and exhaled breath.View evidenceHide evidence

As stated28 participants; 18 had recently experienced a respiratory tract infection

Why this verdict

The profile supports the sample size of 28 healthcare workers, paired serum/nasal/PExA sampling, and that 18 participants had RT-qPCR-confirmed respiratory virus infection. However, the specific COMMUNITY cohort and Danderyd Hospital details are not present in the abstract-level profile, so those portions are not verifiable here.

1

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
2

Study evidence

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001

“Strong correlations (Spearman's rho >0.85, p < 0.0001) were observed between PExA and serum IgG”
Claim 4 of 6SupportedUsing a noninvasive method called PExA, researchers collected tiny exhaled particles from the respiratory tract lining fluid of the small airways and analyzed them for virus-specific antibodies.View evidenceHide evidence

Why this verdict

The profile states that PExA is a non-invasive method capturing aerosolised respiratory tract lining fluid from distal airways and that antigen-specific IgA and IgG were quantified in those PExA samples. This matches the story’s description of collecting exhaled particles from small-airway RTLF and analyzing them for virus-specific antibodies.

1

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
Claim 5 of 6SupportedIn exhaled breath samples, the researchers detected IgA and IgG antibodies directed against SARS-CoV-2, influenza virus, and RSV; lower-airway IgG largely mirrored blood levels, while IgA showed a different pattern consistent with greater local mucosal antibody responses.View evidenceHide evidence

Why this verdict

The profile supports quantification of antigen-specific IgA and IgG in PExA samples for SARS-CoV-2 spike, influenza A H1, and RSV pre-F antigens. It also supports strong PExA-serum IgG correlations and more modest IgA correlations, consistent with different compartmental antibody patterns. The story’s wording is acceptable because it frames the local mucosal interpretation as “consistent with,” although the profile notes that antibody origin/local production is inferential and not causally established.

1

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
2

Study evidence

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001

“Strong correlations (Spearman's rho >0.85, p < 0.0001) were observed between PExA and serum IgG”
Claim 6 of 6SupportedThe researchers say the method could help investigate how lower-airway immune responses change after respiratory infections or vaccinations and may support evaluation of preventive treatments, but they stress that this was an initial methodological study and further validation in larger studies is needed.View evidenceHide evidence

Why this verdict

The profile supports the method as a proof-of-concept for non-invasive study of antigen-specific lower-airway antibodies and notes relevance to mucosal vaccine development. The story appropriately hedges future applications and includes key caveats that this was a small proof-of-concept study needing further validation. Claims about evaluation of preventive interventions are somewhat general, but they are consistent with the profile’s stated vaccine-development context.

1

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
2

Study evidence

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001

“Strong correlations (Spearman's rho >0.85, p < 0.0001) were observed between PExA and serum IgG”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Technical performance/assay repeatability was part of the paper’s feasibility claim, with low variability reported for selected antigen-specific IgA measures in PExA.

    The story says the method successfully measured antibodies but does not mention the reported coefficients of variation or the analytical precision evidence that underpins the feasibility claim.

    From Non-invasive PExA sampling; paired biospecimen comparison; analytical precision assessment

  • The cross-compartment findings are observational and correlational; they do not prove the origin of antibodies or establish local production versus systemic transfer.

    The story uses relatively cautious language, but its caveats do not explicitly state that the local mucosal interpretation is inferential and that causality/source of antibodies is not established.

    From Observational paired-sample cross-sectional analysis (human, in vivo)

5 things the story did carry across
  • Proof-of-concept demonstration that PExA can non-invasively collect distal-airway RTLF/exhaled particles and quantify antigen-specific IgA and IgG.
  • Paired multi-compartment sampling was conducted in 28 healthcare workers, including 18 with RT-qPCR-confirmed respiratory virus infection, using PExA, serum, and nasal secretions.
  • PExA IgG strongly correlated with serum IgG, whereas PExA-serum IgA correlations were more modest.
  • The IgA/IgG ratio was higher in nasal secretions than in PExA, indicating different isotype distributions between upper and lower airway compartments.
  • Small proof-of-concept sample limits precision and generalizability.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoDemonstrate feasibility and technical performance (repeatability/variability) of using Particles in Exhaled Air (PExA) to non-invasively quantify distal-airway (RTLF) antigen-specific IgA and IgG.Non-invasive PExA sampling; paired biospecimen comparison; analytical precision assessmentExpand

In plain English

Proof-of-concept observational study showing that non-invasive PExA sampling of exhaled breath particles (distal-airway RTLF) can be used to quantify antigen-specific IgA and IgG with low measured variability; paired serum and nasal samples in 28 healthcare workers (18 with RT-qPCR-confirmed infection) were used to assess assay performance and compartment correlations.

Key findings

  • PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.
  • Measurements in PExA correlated strongly with serum for IgG.Spearman's rho > 0.85 (p < 0.0001) between PExA and serum IgG.
“We used Particles in Exhaled Air (PExA), a non-invasive method capturing aerosolised respiratory tract lining fluid (RTLF) from the distal airways, to quantify antigen-specific IgA and IgG.”
What this piece can’t prove
  • Small proof-of-concept sample (28 participants) limits precision of estimates and generalizability.
  • Abstract does not specify the immunoassay platform, limits replication and assessment of analytical validity beyond reported CVs.

1 further detail could not be confirmed from the summary.

2human in vivoCharacterize biological relationships between lower-airway (PExA) antibodies and paired systemic/upper-airway compartments (serum and nasal secretions), including correlations and isotype-ratio differences.Observational paired-sample cross-sectional analysis (human, in vivo)Expand

In plain English

Within 28 participants sampled pairwise (PExA lower-airway RTLF, serum, nasal secretions), antigen-specific IgG measured in PExA strongly correlated with serum IgG (Spearman's rho >0.85, p<0.0001), whereas antigen-specific IgA correlations with serum were more modest. Both IgG and IgA in PExA correlated with nasal secretions. The IgA/IgG ratio was substantially higher in nasal secretions than in PExA (median 5.0 vs 0.6, p<0.0001), consistent with different isotype distributions between upper and lower airway compartments.

Key findings

  • Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001
  • Antigen-specific IgA correlations between PExA and serum were more modest than for IgG.
“Strong correlations (Spearman's rho >0.85, p < 0.0001) were observed between PExA and serum IgG”
What this piece can’t prove
  • Relatively small sample size (n=28) limits precision and generalisability.
  • Correlational data do not prove the origin of antibodies (systemic transfer vs local production); interpretation of source is inferential.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

Differential Recognition of Diet-Derived Neu5Gc-Neoantigens on Glycan Microarrays by Carbohydrate-Specific Pooled Human IgG and IgA Antibodies

Crossref

Source (opens in a new tab)

And 9 more candidates considered.